IN2014MN01376A - - Google Patents

Info

Publication number
IN2014MN01376A
IN2014MN01376A IN1376MUN2014A IN2014MN01376A IN 2014MN01376 A IN2014MN01376 A IN 2014MN01376A IN 1376MUN2014 A IN1376MUN2014 A IN 1376MUN2014A IN 2014MN01376 A IN2014MN01376 A IN 2014MN01376A
Authority
IN
India
Prior art keywords
ihmvyskrsgkprgyafiey
peptide
salt
amino acid
acid sequence
Prior art date
Application number
Inventor
Sylviane Muller
Jean Paul Briand
Robert Zimmer
Original Assignee
Centre Nat Rech Scient
Immupharma France Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Immupharma France Sa filed Critical Centre Nat Rech Scient
Publication of IN2014MN01376A publication Critical patent/IN2014MN01376A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The present invention relates to a peptide or a salt thereof comprising or consisting of the amino acid sequence IHMVYSKRSGKPRGYAFIEY comprising one or more post translational modifications.
IN1376MUN2014 2011-12-13 2011-12-13 IN2014MN01376A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2011/003256 WO2013088194A1 (en) 2011-12-13 2011-12-13 Modified peptides and their use for treating autoimmune diseases

Publications (1)

Publication Number Publication Date
IN2014MN01376A true IN2014MN01376A (en) 2015-04-17

Family

ID=45607295

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1376MUN2014 IN2014MN01376A (en) 2011-12-13 2011-12-13

Country Status (14)

Country Link
US (2) US9657072B2 (en)
EP (2) EP2790715B1 (en)
JP (1) JP6060175B2 (en)
KR (2) KR101728784B1 (en)
CN (2) CN106986927A (en)
AU (2) AU2011383222C1 (en)
BR (1) BR112014014492B1 (en)
CA (1) CA2858957C (en)
DK (2) DK3202413T3 (en)
ES (1) ES2618402T3 (en)
HU (1) HUE032552T2 (en)
IN (1) IN2014MN01376A (en)
RU (1) RU2620070C2 (en)
WO (1) WO2013088194A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10213482B2 (en) * 2014-12-12 2019-02-26 Immupharma France Sa Methods of treating chronic inflammatory diseases
US11485991B2 (en) 2016-04-05 2022-11-01 Council Of Scientific & Industrial Research Multifunctional recombinant nucleotide dependent glycosyltransferase protein and its method of glycosylation thereof
WO2018109285A1 (en) * 2016-12-13 2018-06-21 Centre National De La Recherche Scientifique Peptides for the treatment of neurolupus
WO2021198135A1 (en) * 2020-03-29 2021-10-07 Immupharma France Sa Method of treating viral infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US6696545B1 (en) * 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
EP1425295B1 (en) 2001-09-06 2009-12-23 Centre National De La Recherche Scientifique (Cnrs) Modified peptides and their use for the treatment of autoimmune diseases
FR2829768B1 (en) * 2001-09-18 2003-12-12 Centre Nat Rech Scient USE OF PEPTIDES COMPRISING POST-TRANSLATIONAL TYPE MODIFICATIONS IN THE TREATMENT OF AUTOIMMUNE CONDITIONS
US7884184B2 (en) * 2007-01-30 2011-02-08 Epivax, Inc. Regulatory T cell epitopes, compositions and uses thereof
FR2931360B1 (en) * 2008-05-20 2012-05-18 Centre Nat Rech Scient NANOPARTICLES CONTAINING A PEPTIDE, VECTORS CONTAINING SAME AND PHARMACEUTICAL USES OF SAID NANOPARTICLES AND VECTORS

Also Published As

Publication number Publication date
BR112014014492A2 (en) 2020-10-27
US20170226167A1 (en) 2017-08-10
JP6060175B2 (en) 2017-01-11
EP2790715B1 (en) 2016-12-07
BR112014014492B1 (en) 2022-05-24
ES2618402T3 (en) 2017-06-21
AU2011383222B2 (en) 2016-10-27
JP2015501831A (en) 2015-01-19
KR20170020556A (en) 2017-02-22
KR101728784B1 (en) 2017-04-21
AU2017200207B2 (en) 2018-03-01
DK2790715T3 (en) 2017-03-20
RU2620070C2 (en) 2017-05-22
AU2011383222A1 (en) 2014-07-03
EP3202413A1 (en) 2017-08-09
WO2013088194A1 (en) 2013-06-20
CN104114180B (en) 2017-01-18
EP3202413B1 (en) 2018-08-01
AU2017200207A1 (en) 2017-02-02
CA2858957A1 (en) 2013-06-20
CA2858957C (en) 2019-09-03
KR20140114365A (en) 2014-09-26
RU2014128612A (en) 2016-02-10
DK3202413T3 (en) 2018-11-19
US9657072B2 (en) 2017-05-23
HUE032552T2 (en) 2017-09-28
CN106986927A (en) 2017-07-28
EP2790715A1 (en) 2014-10-22
US20150111835A1 (en) 2015-04-23
AU2011383222C1 (en) 2017-04-20
CN104114180A (en) 2014-10-22

Similar Documents

Publication Publication Date Title
IL274204B (en) Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
HK1216013A1 (en) Zinc amino acid halide mouthwashes
HK1216011A1 (en) Zinc amino acid trimethylglycine halide
HK1219892A1 (en) Amino diacids containing peptide modifiers
IL229353A0 (en) Compositions containing ,methods involving ,and uses of non-natural amino acid linked dolastatin deriv atives
HK1211569A1 (en) Amino acid derivatives
EP2771033A4 (en) Protein formulations containing amino acids
MY167847A (en) Intra-mode video coding
DK2797616T3 (en) CELL-PENETRATING PEPTIDES
EP2709645A4 (en) Improved peptide pharmaceuticals
EP2813487A4 (en) Basic amino acid derivative
IL238777A0 (en) Dermal compositions containing unnatural hygroscopic amino acids
UA118167C2 (en) Peptides and their use
TWI561242B (en) Long-acting peptide analogs
WO2013000922A9 (en) Ccr2 antagonist peptides
EP2813488A4 (en) Amphoteric ion-type basic amino acid derivative
SG10201606218WA (en) Purified Proteins
GB201111183D0 (en) Peptide
IN2014DN09367A (en)
MX351610B (en) ACID ADDITION SALTS OF 5a-HYDROXY-6ß-[2-(1H-IMIDAZOL-4-YL)ETHYL AMINO]CHOLESTAN-3ß-OL.
IN2014MN01376A (en)
MX2014006869A (en) Expression cassette.
EP2881382A4 (en) Method for producing basic amino acid or basic amino acid salt
EP2550251A4 (en) Process for producing sulfur-containing amino acid or salt thereof
EP3067430A4 (en) Method for producing d-form or l-form amino acid derivative having thiol group